Association Between Vitamin D Levels and Long COVID Signs and Symptoms.

Association Between Vitamin D Levels and Long COVID Signs and Symptoms.

Publication date: Sep 18, 2025

“Long COVID” refers to a condition in which individuals continue to experience persistent signs and symptoms even after recovering from the initial COVID-19 infection. Signs and symptoms that persist can affect multiple organs in the body. Vitamin D is an essential nutrient that plays a crucial role, particularly in the immune system, and may be linked to the development of long COVID. The study aimed to investigate the association between vitamin D levels and the prevalence of long COVID signs and symptoms in COVID-19 patients. The study enrolled 170 COVID-19 patients with mild signs and symptoms and confirmed COVID-Ag or RT-PCR tests. The subjects were aged 18-59 years. All patients had 25(OH)D levels measured within 60 days of COVID-19 diagnosis and had been followed for at least 3 months post-infection. Data collected included demographic characteristics, serum 25(OH)D levels, and self-reported long COVID signs and symptoms questionnaire responses. The study results indicated a female-to-male ratio of 1. 1:1 and a mean age of 45. 87 +/- 8. 65 years; of these, 62. 4% received three doses of the COVID-19 vaccine, and 64. 7% developed long COVID. The most prevalent signs and symptoms were respiratory (55. 3%), skin (50. 6%), and general (39. 4%). The median blood vitamin D level was 22. 96 ng/mL, with 41. 2% of subjects having insufficient levels, 30. 6% having deficient levels, and 28. 2% having sufficient levels. Patients with long COVID had significantly lower vitamin D levels compared with those without long COVID (21. 52 ng/mL vs. 25. 46 ng/mL; p

Open Access PDF

Concepts Keywords
Covid Adolescent
Months Adult
Pcr COVID-19
Sunlight COVID-19
Vaccine Female
Humans
long COVID
Male
Middle Aged
Prevalence
SARS-CoV-2
Vitamin D
Vitamin D
vitamin D
Vitamin D Deficiency
Young Adult

Semantics

Type Source Name
drug DRUGBANK Vitamin D
disease MESH Long COVID
disease MESH COVID-19
disease MESH infection
disease IDO role
pathway REACTOME Immune System
disease IDO blood
disease MESH vitamin D deficiency
drug DRUGBANK Coenzyme M
disease MESH vitamin deficiency
disease IDO production
disease MESH Sequelae
disease IDO history
disease MESH syndrome
disease MESH chest pain
disease MESH smell loss
disease MESH hair loss
disease MESH joint pain
disease MESH anxiety
disease MESH depression
pathway REACTOME Vitamins
drug DRUGBANK Ribostamycin
disease IDO protein

Original Article

(Visited 9 times, 1 visits today)

Leave a Comment

Your email address will not be published. Required fields are marked *